Kemnay Advisory Services Inc. Amarin Corp Plcuk Transaction History

Kemnay Advisory Services Inc.

  • $552 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$13.94 - $24.12 $1.03 Million - $1.78 Million
-73,727 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$13.89 - $23.16 $1.02 Million - $1.71 Million
73,727 New
73,727 $1.12 Million
Q2 2019

Aug 14, 2019
SELL
$16.27 - $20.51 $1.22 Million - $1.54 Million
-75,038 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$12.61 - $22.33 $946,229 - $1.68 Million
75,038 New
75,038 $1.56 Million

Others Institutions Holding AMRN

# of Institutions
184
Shares Held
71.2M
Call Options Held
183K
Put Options Held
66.7K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Kemnay Advisory Services Inc. Portfolio

Follow Kemnay Advisory Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kemnay Advisory Services Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email